Impact Stories | McMaster University

A McMaster University team is collaborating in a major nationwide study on the effectiveness of COVID-19 vaccines in people with immune-mediated inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease and psoriasis.

An interdisciplinary team of researchers from McMaster and SickKids are developing a cutting-edge lung model that can better respond to viruses and drug treatments, giving scientists a tool to advance research in lung conditions like COVID-19, cystic fibrosis and allergens for asthma and air pollution....

For Elise Thomsen, it began with a searing headache behind the eyes. Three hours later, she received a phone call from her son’s daycare, warning of a COVID-19 outbreak, and Thomsen knew she had it....

A McMaster University team of researchers has found how, exactly, the COVID-19 vaccines that use adenovirus vectors trigger a rare but sometimes fatal blood clotting reaction called vaccine-induced immune thrombotic thrombocytopenia or VITT....

Immunologists at McMaster University have discovered a previously unknown mechanism which acts like a spider web, trapping and killing pathogens such as influenza or SARS-CoV-2, the virus responsible for COVID-19....

McMaster researchers are leading a pan-Canadian study investigating the immune response to the COVID-19 vaccine within the South Asian community....

A team of virologists, infectious disease experts and immunologists at McMaster is developing two new second-generation COVID-19 vaccine candidates, designing and producing them in a specialized facility on campus....

Two Canadian powerhouses in infectious disease research have joined forces in the fight against COVID–19, leading Canada’s response and preparedness for future pandemics....

To ensure decision-makers have access to the best COVID-19 science in a timely manner, the federal government is investing $1 million to support the COVID-19 Evidence Network to support Decision-makers (COVID-END) hosted at McMaster University....

Last year when a multidisciplinary team of McMaster researchers created a viable new vaccine-delivery platform that does not rely on refrigeration, they hoped it might help get life-saving vaccines to remote locations....